P W Grigsby

Summary

Affiliation: Washington University School of Medicine
Country: USA

Publications

  1. ncbi Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group
    P W Grigsby
    Washington University Medical Center, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 44:513-7. 1999
  2. ncbi Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery
    P W Grigsby
    Radiation Oncology Center, Mallinckrodt Institute of Radiology, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 45:645-51. 1999
  3. ncbi Factors affecting long-term outcome of irradiation in carcinoma of the vagina
    C A Perez
    Radiation Oncology Center, Mallinckrodt Institute of Radiology, Washington University Medical Center, St Louis, MO, USA
    Int J Radiat Oncol Biol Phys 44:37-45. 1999
  4. ncbi Radiation therapy for carcinoma of the cervix with biopsy-proven positive para-aortic lymph nodes
    P W Grigsby
    Radiation Oncology Center, Mallinckrodt Institute of Radiology, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 49:733-8. 2001
  5. ncbi Current management of patients with invasive cervical carcinoma
    P W Grigsby
    Mallinckrodt Institute of Radiology, Box 8224, Washington University Medical Center, 4939 Children s Place, Suite 5500, St Louis, MO 63110, USA
    Clin Obstet Gynecol 44:531-7. 2001
  6. ncbi Lymph node staging by positron emission tomography in patients with carcinoma of the cervix
    P W Grigsby
    Mallinckrodt Institute of Radiology and the Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, USA
    J Clin Oncol 19:3745-9. 2001
  7. ncbi Comparison of clinical outcome in black and white women treated with radiotherapy for cervical carcinoma
    P W Grigsby
    Radiation Oncology Center, Mallinckrodt Institute of Radiology, St Louis, Missouri 63110, USA
    Gynecol Oncol 79:357-61. 2000
  8. ncbi Cervical cancer: combined modality therapy
    P W Grigsby
    Mallinckrodt Institute of Radiology, Washington University Medical Center, St Louis, Missouri 63110, USA
    Cancer J 7:S47-50. 2001
  9. ncbi Nuclear imaging and cervical cancer
    P W Grigsby
    Department of Radiation Oncology, Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Department of Obstetrics and Gynecology, Alvin J Siteman Cancer Center, Washington University Medical Center, St Louis, MO 63110, USA
    Minerva Ginecol 61:45-51. 2009
  10. ncbi Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes
    P W Grigsby
    Radiation Oncology Center, Washington University Medical Center, St. Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 51:982-7. 2001

Collaborators

Detail Information

Publications17

  1. ncbi Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group
    P W Grigsby
    Washington University Medical Center, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 44:513-7. 1999
    ..This is a report of the final results of the study...
  2. ncbi Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery
    P W Grigsby
    Radiation Oncology Center, Mallinckrodt Institute of Radiology, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 45:645-51. 1999
    ..The purpose of this analysis was to evaluate the prognostic significance of cervical tumor size in patients with Stages Ib and IIa carcinoma of the cervix treated with preoperative irradiation and radical or conservative hysterectomy...
  3. ncbi Factors affecting long-term outcome of irradiation in carcinoma of the vagina
    C A Perez
    Radiation Oncology Center, Mallinckrodt Institute of Radiology, Washington University Medical Center, St Louis, MO, USA
    Int J Radiat Oncol Biol Phys 44:37-45. 1999
    ..This report evaluates prognostic and technical factors affecting outcome of patients with primary carcinoma of the vagina treated with definitive radiation therapy...
  4. ncbi Radiation therapy for carcinoma of the cervix with biopsy-proven positive para-aortic lymph nodes
    P W Grigsby
    Radiation Oncology Center, Mallinckrodt Institute of Radiology, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 49:733-8. 2001
    ..To evaluate local tumor control, cause-specific survival, patterns of relapse, and toxicity in patients with cervical cancer and positive para-aortic lymph nodes treated with radiation therapy alone...
  5. ncbi Current management of patients with invasive cervical carcinoma
    P W Grigsby
    Mallinckrodt Institute of Radiology, Box 8224, Washington University Medical Center, 4939 Children s Place, Suite 5500, St Louis, MO 63110, USA
    Clin Obstet Gynecol 44:531-7. 2001
    ..Further refinement of treatment for those patients who require combined chemo/radiation versus those with comorbidities such that combination chemotherapy is actually too toxic must be defined...
  6. ncbi Lymph node staging by positron emission tomography in patients with carcinoma of the cervix
    P W Grigsby
    Mallinckrodt Institute of Radiology and the Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, USA
    J Clin Oncol 19:3745-9. 2001
    ....
  7. ncbi Comparison of clinical outcome in black and white women treated with radiotherapy for cervical carcinoma
    P W Grigsby
    Radiation Oncology Center, Mallinckrodt Institute of Radiology, St Louis, Missouri 63110, USA
    Gynecol Oncol 79:357-61. 2000
    ..The purpose of this investigation was to evaluate the significance of race on the cancer-specific survival outcome of women treated with radiotherapy for advanced-stage cancer of the uterine cervix...
  8. ncbi Cervical cancer: combined modality therapy
    P W Grigsby
    Mallinckrodt Institute of Radiology, Washington University Medical Center, St Louis, Missouri 63110, USA
    Cancer J 7:S47-50. 2001
    ..These findings are summarized with respect to their implications fortreatment of patients with advanced cervical cancer...
  9. ncbi Nuclear imaging and cervical cancer
    P W Grigsby
    Department of Radiation Oncology, Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Department of Obstetrics and Gynecology, Alvin J Siteman Cancer Center, Washington University Medical Center, St Louis, MO 63110, USA
    Minerva Ginecol 61:45-51. 2009
    ....
  10. ncbi Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes
    P W Grigsby
    Radiation Oncology Center, Washington University Medical Center, St. Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 51:982-7. 2001
    ..One patient died of acute complications of therapy. The survival estimates seem no better than standard fractionation irradiation without chemotherapy...
  11. ncbi FDG-PET/CT: new horizons in anal cancer
    P W Grigsby
    Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University Medical Center, Saint Louis, Missouri, USA
    Gastroenterol Clin Biol 33:456-8. 2009
    ..This imaging modality can also be used to evaluate sites of recurrent disease. FDG-PET/CT is an imaging modality which greatly affects the management of patients with anal cancer...
  12. ncbi Radiation exposure from outpatient radioactive iodine (131I) therapy for thyroid carcinoma
    P W Grigsby
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA
    JAMA 283:2272-4. 2000
    ..In May 1997, the US Nuclear Regulatory Commission (NRC) revised its patient release regulations, allowing for outpatient administration of larger activities of sodium iodide 131I than previously permitted...
  13. ncbi Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation
    L Portelance
    Department of Radiology, Radiation Oncology Center, Mallinckrodt Institute of Radiology, Washington University Medical Center, St. Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 51:261-6. 2001
    ..48 +/- 31.80%) techniques (p < 0.05). CONCLUSION: In this dosimetric study, we demonstrated that with similar target coverage, normal tissue sparing is superior with IMRT in the treatment of cervical cancer...
  14. ncbi Gene expression patterns in advanced human cervical cancer
    P W Grigsby
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri, USA
    Int J Gynecol Cancer 16:562-7. 2006
    ..Both overall and cause-specific survivals were different between these two patient groups (P= 0.006). This limited data set identified candidate biomarkers of extent of lymph node metastases that correlated with poor survival outcome...
  15. ncbi Prospective phase I/II study of irradiation and concurrent chemotherapy for recurrent cervical cancer after radical hysterectomy
    P W Grigsby
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO 63110, USA
    Int J Gynecol Cancer 14:860-4. 2004
    ..By logistic regression, the only significant factor for survival was total irradiation dose (P = 0.04). In conclusion, long-term survival with this treatment regimen is possible but is accompanied by significant late toxicity...
  16. ncbi Cervical tumor control evaluated with ICRU 38 reference volumes and integrated reference air kerma
    P W Grigsby
    Radiation Oncology Center, Mallinckrodt Institute of Radiology, Washington University School of Medicine, MO, St. Louis, USA
    Radiother Oncol 58:19-23. 2001
    ..001). CONCLUSION: Analysis of the 60-160 Gy reference volumes and IRAK failed to demonstrate a consistent positive increasing correlation of these values to primary cervical tumor control...
  17. ncbi Postoperative vaginal brachytherapy alone is the treatment of choice for grade 1-2, stage IC endometrial cancer
    M Cengiz
    Department of Radiation Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
    Int J Gynecol Cancer 15:926-31. 2005
    ..However, vaginal cuff brachytherapy alone produced significantly less toxicity...